Results 111 to 120 of about 210,319 (126)

Efficacy and Safety of Dopamine Agonists in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials

Journal of Neurotrauma, 2012
Anne Julie Frenette, Dean Fergusson
exaly  

A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease

Expert Opinion on Drug Safety, 2016
Ubaldo Bonuccelli, Roberto Ceravolo, Eleonora del Prete   +2 more
exaly  

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

Clinical Therapeutics, 2006
exaly  

Hemodynamic Effects of Selective Dopamine Receptor Agonists in the Rat and Dog

Clinical and Experimental Hypertension, 1987
J Paul Hieble, R M Demarinis, Robert M Demarinis   +2 more
exaly  

Cancer risks among the users of ergot-derived dopamine agonists for Parkinson's disease, a nationwide population-based survey

Parkinsonism and Related Disorders, 2015
Vinchi Wang, Chia-Hung Kao, Che-Chen Lin   +2 more
exaly  

Dopamine uptake by the human platelet: effects of dopamine receptor agonists

European Journal of Pharmacology, 1989
Brian Dean, David Copolov, D L Copolov
exaly  

DOPAMINE AGONISTS AND REFLEX EPILEPSY

1977
G M, Anlezark, R W, Horton, B S, Meldrum
openaire   +2 more sources

High dose dopamine agonist treatment and combination of dopamine agonists

Aktuelle Neurologie, 2005
P Odin, C Oehlwein, A Storch, U Polzer, G Werner, R Renner, M Shing, A Ludolph, P Schüler   +8 more
openaire   +1 more source

Dopamine Agonists

openaire   +2 more sources

Etiology of OHSS and use of dopamine agonists

Fertility and Sterility, 2012
exaly